Valeant Pharmaceuticals Trading Higher

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares are trading higher by $5 at $98.77 in Monday's session.

A dire warning from Citron's Andrew Left along with a Jefferies downgrade has not instigated another leg lower in the volatile issue. Instead, it managed to trek higher, and after a brief retreat to $94.50, was able to climb back into triple digits, reaching $102.89 before falling falling back under $100.

The low for the current down move stands at $88.50; the lowest close for the move was on Friday at $93.77.